FOXA1 directly binds to the MND1 promoter to suppress its transcription, and this suppression-mediated activation of the PI3K/AKT signaling axis concomitantly inhibited gastric cancer progression and enhanced oxaliplatin chemosensitivity [41]. Here, FOXA1 is linked to gastric cancer.